Heartflow, Inc. HTFL
54.00 USD -2.57 (-4.54%)
Nov 5, 2026, 12:07 PM EST
53.16 Day range 56.78
20.13 52-week range 60.56
- YTD
- +85.25%
- 1 year
- +55.58%
News
benzinga.com Heartflow To Present DECIDE Registry Data Showing 34% Reduction In Major Cardiovascular Events With AI Plaque Analysis, At AHA Scientific Sessions 2026 First plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs. approximately 35% with CCTA alone. GAMEFILM data highlight…
globenewswire.com AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry First plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs.
globenewswire.com TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients Late-Breaking P4 study, simultaneously published in NEJM, shows CT guidance delivers matched one-year clinical outcomes with shorter procedures, demonstrating pre-procedural CCTA can guide key PCI…
prnewswire.com Boston Scientific announces results for third quarter 2026 MARLBOROUGH, Mass., Oct. 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.138 billion during the third quarter of 2026, growing 1.5 percent on a reported,…
defenseworld.net Heartflow (NASDAQ:HTFL) Insider Campbell Rogers Sells 23,933 Shares of Stock Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) insider Campbell Rogers sold 23,933 shares of the business's stock in a transaction dated Thursday, October 22nd. The stock was sold at an average…
benzinga.com Elucid Bioimaging Says Co Is Aware Of A Lawsuit Filed By Heartflow, On October 22, 2026. Elucid Will Respond To And Defend Against The Claims In The Lawsuit Through The Appropriate Legal Channels Elucid Bioimaging Inc. ("Elucid") today reaffirmed its commitment to advancing its mission – the prediction and personalization of the prevention of heart attack and stroke – and its confidence in…
benzinga.com Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $64 Piper Sandler analyst Matt OBrien reiterates HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $45 to $64.
globenewswire.com Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026 SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced it…
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
defenseworld.net Heartflow (NASDAQ:HTFL) Sets New 12-Month High – Should You Buy? Heartflow, Inc. (NASDAQ: HTFL - Get Free Report)'s stock price hit a new 52-week high on Monday. The company traded as high as $52.49 and last traded at $51.8950, with a volume of 819255 shares…- benzinga.com Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56 Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $45 to $56.
defenseworld.net Vikram Verghese Sells 7,579 Shares of Heartflow (NASDAQ:HTFL) Stock Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) CFO Vikram Verghese sold 7,579 shares of the firm's stock in a transaction on Thursday, September 17th. The stock was sold at an average price of…
defenseworld.net Heartflow (NASDAQ:HTFL) Reaches New 52-Week High – Still a Buy? Heartflow, Inc. (NASDAQ: HTFL - Get Free Report)'s share price reached a new 52-week high during trading on Friday. The company traded as high as $52.22 and last traded at $51.2010, with a volume of…
defenseworld.net 12,278 Shares in Heartflow, Inc. $HTFL Bought by Amundi Amundi bought a new stake in Heartflow, Inc. (NASDAQ: HTFL) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The…
defenseworld.net John C.M. Farquhar Sells 35,010 Shares of Heartflow (NASDAQ:HTFL) Stock Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) CEO John Farquhar sold 35,010 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $46.42, for…
fool.com HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High The transaction involved 38,900 shares valued at ~$1.8 million based on a weighted average price of $46.78 per share. The executive traded shares equal to 11% of the equity stake held before the…
defenseworld.net Heartflow (NASDAQ:HTFL) versus American Well (NYSE:AMWL) Financial Analysis American Well (NYSE: AMWL - Get Free Report) and Heartflow (NASDAQ: HTFL - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on…
benzinga.com UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55 UBS analyst Doug Schenkel initiates coverage on HeartFlow (NASDAQ:HTFL) with a Neutral rating and announces Price Target of $55.
fool.com HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High The sale of 33,416 shares generated a total value of approximately $1.7 million based on a weighted average execution price of $49.85. The traded shares represent 13% of the equity stake held by the…
seekingalpha.com Baron SMID Cap ETF Q2 2026 Portfolio Activity During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufacturer of stormwater and onsite wastewater management products. We view Axon Enterprise as a market…
defenseworld.net Bank of New York Mellon Corp Makes New $19.10 Million Investment in Heartflow, Inc. $HTFL Bank of New York Mellon Corp bought a new stake in shares of Heartflow, Inc. (NASDAQ: HTFL) during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund…
defenseworld.net BlackRock Inc. Makes New $152.50 Million Investment in Heartflow, Inc. $HTFL BlackRock Inc. acquired a new stake in Heartflow, Inc. (NASDAQ: HTFL) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The…
globenewswire.com Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty,…
globenewswire.com Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference SAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced…
fool.com HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors? The executive sold 9,219 shares at $41.23 per share on August 17, 2026, generating ~$380,100. The transaction reduced the insider's direct equity position by 10%, while total beneficial ownership…
seekingalpha.com HeartFlow: An Impressive MedTech Growth Play HeartFlow delivered a convincing Q2 with 48% sales growth and gross margins rising to 83%, driving strong market optimism. The company raised full-year revenue guidance to $246–$250 million, though…
benzinga.com HeartFlow Shares Soar Following Strong Q2 Results and Upgraded Guidance HeartFlow shares are surging Friday after it reported better-than-expected Q2 adjusted EPS results and raised its full-year outlook.- benzinga.com Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45 Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $37 to $45.
- benzinga.com Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40 Morgan Stanley analyst Patrick Wood maintains HeartFlow (NASDAQ:HTFL) with a Equal-Weight and raises the price target from $35 to $40.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular session. The company's market cap stands at $23.7 million. The company's, Q2 earnings came out yesterday.- benzinga.com Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45 Piper Sandler analyst Matt OBrien reiterates HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $38 to $45.
benzinga.com JP Morgan Maintains Overweight on HeartFlow, Raises Price Target to $45 JP Morgan analyst Robbie Marcus maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $35 to $45.- benzinga.com Wells Fargo Maintains Overweight on HeartFlow, Raises Price Target to $39 Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $37 to $39.
benzinga.com Heartflow, Eton Pharmaceuticals, Nu Holdings And Other Big Stocks Moving Higher On Friday U.S. stocks up, Dow Jones 0.1% higher. HeartFlow (HTFL) shares rise 26.5% on better-than-expected earnings. Other big gains include ETON, VALN, IMXI.
benzinga.com Stifel Maintains Buy on HeartFlow, Raises Price Target to $45 Stifel analyst Rick Wise maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $40 to $45.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Capricor Therapeutics (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market session. The company's market cap stands at $243.8 million. As per the news, the Q2 earnings report…
benzinga.com Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results and issuing FY26 revenue guidance above estimates.
benzinga.com HeartFlow Q2 2026 Earnings Call Transcript HeartFlow (NASDAQ:HTFL) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For…- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session. The company's market cap stands at $2.9 million. Capricor Therapeutics (NASDAQ:CAPR) stock moved…
benzinga.com CORRECTION: HeartFlow Q2 Adj. EPS $(0.07) Beats $(0.13) Estimate, Sales $53.190M Miss $56.642M Estimate HeartFlow (NASDAQ:HTFL) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.13) by 46.15 percent. This is a 97.49 percent increase over losses of $(2.79)…- benzinga.com HeartFlow Raises FY2026 Sales Guidance from $218.000M-$222.000M to $246.000M-$250.000M vs $230.073M Est HeartFlow (NASDAQ:HTFL) raises FY2026 sales outlook from $218.000 million-$222.000 million to $246.000 million-$250.000 million vs $230.073 million estimate.
benzinga.com This Faeth Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Wall Street analysts changed outlook on top names. Check ratings page for upgrades, downgrades, initiations. See other analysts' views on HTFL, SKYH, FTH.- benzinga.com Baird Initiates Coverage On HeartFlow with Outperform Rating, Announces Price Target of $34 Baird analyst David Rescott initiates coverage on HeartFlow (NASDAQ:HTFL) with a Outperform rating and announces Price Target of $34.
benzinga.com Freedom Capital Markets Initiates Coverage On HeartFlow with Buy Rating, Announces Price Target of $37 Freedom Capital Markets analyst Gene Mannheimer initiates coverage on HeartFlow (NASDAQ:HTFL) with a Buy rating and announces Price Target of $37.- benzinga.com Canaccord Genuity Maintains Buy on HeartFlow, Lowers Price Target to $37 Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and lowers the price target from $43 to $37.
benzinga.com Wells Fargo Maintains Overweight on HeartFlow, Raises Price Target to $37 Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $35 to $37.
benzinga.com Transcript: HeartFlow Q1 2026 Earnings Conference Call - benzinga.com HeartFl232.000M vsow Raises FY2026 Sales Guidance from $218.000M-$222.000M to $228.000M-$ $220.412M Est HeartFlow (NASDAQ:HTFL) raises FY2026 sales outlook from $218.000 million-$222.000 million to $228.000 million-$232.000 million vs $220.412 million estimate.
- benzinga.com HeartFlow Q1 Adj. EPS $(0.16) Beats $(0.19) Estimate, Sales $52.587M Beat $49.705M Estimate HeartFlow (NASDAQ:HTFL) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. The company reported quarterly sales of $52.587 million…
benzinga.com Earnings Scheduled For May 14, 2026